Vikki L. Conway, See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 1,427 shares at $13.52 ($19K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Scheduled sale ($19k) by See "Remarks" under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2024-03-01 | $18K | — | Filing → |